1-Year Outcomes of Transcatheter Edge-to-Edge Repair in Anatomically Complex Degenerative Mitral Regurgitation

Robert L Smith1, D Scott Lim2, Linda D Gillam3

  • 1Baylor Scott and White: The Heart Hospital Plano, Plano, Texas, USA.

PubMed

Insights

Transcatheter edge-to-edge repair using the PASCAL system is safe and effective for high-risk patients with degenerative mitral regurgitation. One-year results show significant improvement in heart function and quality of life.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • The CLASP IID Registry evaluated the Edwards PASCAL transcatheter valve repair system.
  • Transcatheter edge-to-edge repair (TEER) is an option for degenerative mitral regurgitation (DMR) in patients unsuitable for surgery.

Purpose of the Study:

  • To assess the 1-year safety and clinical outcomes of TEER with the PASCAL system.
  • To evaluate echocardiographic, functional, and quality-of-life improvements in patients with complex mitral valve anatomy and prohibitive surgical risk.

Main Methods:

  • Prospective enrollment of 98 patients with severe DMR (3+ or 4+) and complex anatomy.
  • Assessment of safety, echocardiographic parameters, and clinical endpoints at 1 year post-procedure.
  • Oversight by a central screening committee, echocardiographic core laboratory, and clinical events committee.

Main Results:

  • One-year Kaplan-Meier estimates for freedom from major adverse events, all-cause mortality, and heart failure hospitalization were 83.5%, 89.3%, and 91.5%, respectively.
  • Significant reduction in mitral regurgitation (MR) was observed, with 93.2% achieving MR ≤2+ and 57.6% achieving MR ≤1+.
  • Substantial improvements in New York Heart Association (NYHA) functional class and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores were noted.

Conclusions:

  • The PASCAL system demonstrated safety and efficacy in reducing MR at 1 year in high-risk patients.
  • Continued improvements in clinical, echocardiographic, functional, and quality-of-life outcomes highlight the PASCAL system's value.
  • TEER with the PASCAL system is a viable treatment option for severe DMR in patients with complex anatomy and prohibitive surgical risk.
Abstract

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
22
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
15
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
40
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
22